Literature DB >> 28882428

The effect of mianserin on the severity of psychosis and dyskinesia in the parkinsonian marmoset.

Adjia Hamadjida1, Stephen G Nuara2, Jim C Gourdon2, Philippe Huot3.   

Abstract

Entities:  

Keywords:  MPTP; Parkinson's disease; dyskinesia; marmoset; mianserin; psychosis

Mesh:

Substances:

Year:  2017        PMID: 28882428     DOI: 10.1016/j.pnpbp.2017.09.001

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


× No keyword cloud information.
  8 in total

Review 1.  5-HT2A blockade for dyskinesia and psychosis in Parkinson's disease: is there a limit to the efficacy of this approach? A study in the MPTP-lesioned marmoset and a literature mini-review.

Authors:  Cynthia Kwan; Imane Frouni; Dominique Bédard; Stephen G Nuara; Jim C Gourdon; Adjia Hamadjida; Philippe Huot
Journal:  Exp Brain Res       Date:  2018-11-15       Impact factor: 1.972

Review 2.  Serotonergic targets for the treatment of L-DOPA-induced dyskinesia.

Authors:  Kathryn Lanza; Christopher Bishop
Journal:  J Neural Transm (Vienna)       Date:  2018-01-05       Impact factor: 3.575

3.  Additive effects of mGluR2 positive allosteric modulation, mGluR2 orthosteric stimulation and 5-HT2AR antagonism on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset.

Authors:  Stephen G Nuara; Jim C Gourdon; Shawn Maddaford; Philippe Huot
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-09-22       Impact factor: 3.000

4.  Evaluation of the effects of the mGlu2/3 antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset.

Authors:  Stephen G Nuara; Jim C Gourdon; Philippe Huot
Journal:  Pharmacol Rep       Date:  2022-06-27       Impact factor: 3.919

5.  Nefazodone reduces dyskinesia, but not psychosis-like behaviours, in the parkinsonian marmoset.

Authors:  Adjia Hamadjida; Stephen G Nuara; Dominique Bédard; Imane Frouni; Cynthia Kwan; Jim C Gourdon; Philippe Huot
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-08-07       Impact factor: 3.000

6.  Trazodone alleviates both dyskinesia and psychosis in the parkinsonian marmoset model of Parkinson's disease.

Authors:  Adjia Hamadjida; Stephen G Nuara; Jim C Gourdon; Philippe Huot
Journal:  J Neural Transm (Vienna)       Date:  2017-12-15       Impact factor: 3.575

Review 7.  Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease.

Authors:  Fabio Del Bello; Mario Giannella; Gianfabio Giorgioni; Alessandro Piergentili; Wilma Quaglia
Journal:  Biomolecules       Date:  2019-04-09

8.  Effect of the mGlu2 positive allosteric modulator CBiPES on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset.

Authors:  Imane Frouni; Cynthia Kwan; Stephen G Nuara; Sébastien Belliveau; Woojin Kang; Adjia Hamadjida; Dominique Bédard; Jim C Gourdon; Philippe Huot
Journal:  J Neural Transm (Vienna)       Date:  2021-01-03       Impact factor: 3.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.